Cargando…
Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression
BACKGROUND: The induction of tumor angiogenesis, a pathologic process critical for tumor progression, is mediated by multiple regulatory factors released by tumor and host cells. We investigated the role of the hematopoietic cytokine erythropoietin as an angiogenic factor that modulates tumor progre...
Autores principales: | Hardee, Matthew E., Cao, Yiting, Fu, Ping, Jiang, Xiaohong, Zhao, Yulin, Rabbani, Zahid N., Vujaskovic, Zeljko, Dewhirst, Mark W., Arcasoy, Murat O. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891087/ https://www.ncbi.nlm.nih.gov/pubmed/17579721 http://dx.doi.org/10.1371/journal.pone.0000549 |
Ejemplares similares
-
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005) -
Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer
por: Kirkpatrick, John P., et al.
Publicado: (2008) -
Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity
por: Rabbani, Zahid N, et al.
Publicado: (2005) -
Erythropoietin Receptor Contributes to Melanoma Cell Survival in vivo
por: Kumar, Suresh M., et al.
Publicado: (2011) -
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007)